| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |